![[del.icio.us]](http://pennystockdd.com/wp-content/plugins/bookmarkify/delicious.png)
![[Digg]](http://pennystockdd.com/wp-content/plugins/bookmarkify/digg.png)
![[Faves]](http://pennystockdd.com/wp-content/plugins/bookmarkify/faves.png)
![[LinkedIn]](http://pennystockdd.com/wp-content/plugins/bookmarkify/linkedin.png)
![[Reddit]](http://pennystockdd.com/wp-content/plugins/bookmarkify/reddit.png)
![[StumbleUpon]](http://pennystockdd.com/wp-content/plugins/bookmarkify/stumbleupon.png)
![[Technorati]](http://pennystockdd.com/wp-content/plugins/bookmarkify/technorati.png)
VocalTec Communications Ltd. (NASDAQ: VOCL) - Shares are down 4.85% and hitting an intraday low of $14.50 after VOCL completed a reverse merger, which tends to move stock prices lower. Will shares bounce back to $16.50? Stay tune.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) jumped 12.88% to $5.26 on 13.96 million shares. Over the past 52-weeks, the stock has been trading in the range of $2.70-$5.93. Arena Pharmaceuticals, Inc. (Arena) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors (GPCRs), in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases
K V Pharma Cl B (KV.B)
|
|||||||||||||||||||||||||||||||||||||
Regards,
Don
More on this topic
(What's this?)
Arena Pharmaceuticals’ Outlook Hinges On Success Of Lorcaserin
(Investment Underground » Page n..., 4/19/12)
Weight Loss Stocks: ARNA, VVUS, and OREX Race to End the Obesity Epidemic
(Money Morning, 4/10/12)
M&A Journal: VocalTec and MagicJack’s YMAX Tie the Knot
(Telecom Ramblings, 7/16/10)
Arena Tumbles Ahead of FDA Review (ARNA, VVUS, OREX)
(tickerspy.com, 9/14/10)
